Cleveland Clinic’s About-Face on the New Alzheimer’s Drug

July 19, 2021

(Axios) – Before the Cleveland Clinic said it would not administer Aduhelm, the new FDA-approved Alzheimer’s drug, the hospital system was promoting the unproven drug on its social media accounts. Why it matters: Cleveland Clinic was the first major medical center to say it would not use Aduhelm, and two hospital systems have followed the clinic’s lead. But the abrupt change could confuse patients, who were told less than two weeks ago by the clinic that the drug offered “hope.” (Read Full Article)